Qianting Zhai
Vice President
Qianting Zhai is an accomplished biotechnology executive with over a decade of experience driving innovation and leading high-performing teams. As the Vice President at Abiosciences, she is responsible for overseeing the company's antibody discovery and development initiatives, leveraging her deep expertise in immunology and protein engineering.
Professional Overview
Qianting is a seasoned leader in the biopharmaceutical industry, with a proven track record of success in antibody discovery, target validation, and early-stage drug development. Her versatile skillset spans technical, managerial, and strategic domains, enabling her to drive impactful projects and foster collaborative, cross-functional partnerships.
Experience Summary
Current Role
As Vice President at Abiosciences, Qianting is responsible for leading the company's antibody discovery and development programs. She oversees a talented team of scientists and engineers, guiding them in the identification, optimization, and preclinical evaluation of novel therapeutic candidates. Under her leadership, Abiosciences has expanded its pipeline and secured several strategic collaborations with industry partners.
Career Progression
Prior to joining Abiosciences, Qianting held progressive roles in the biotech and pharmaceutical sectors. As Head of Antibody Discovery at Kenjockety Biotechnology, she spearheaded the development of a robust antibody platform that yielded several lead candidates for autoimmune and oncology indications. Earlier in her career, she served as an Investigator II at the Novartis Institutes for BioMedical Research (NIBR), where she contributed to the advancement of several small-molecule and biologic programs. Qianting also gained valuable experience as a postdoctoral fellow at Genentech, where she honed her expertise in protein engineering and immunology.
Academic Background
Qianting holds a Ph.D. in Biochemistry from the University of California, San Francisco, where her research focused on the structural and functional characterization of immune receptors. She also earned a B.S. in Molecular Biology from Peking University, graduating with honors.
Areas of Expertise
- Antibody discovery and engineering
- Target identification and validation
- Protein structure-function analysis
- Preclinical development of biologics
- Cross-functional team leadership
- Strategic planning and decision-making
Professional Impact
Under Qianting's leadership, Abiosciences has expanded its antibody pipeline and forged several high-profile industry partnerships, positioning the company as a leader in the field of antibody-based therapeutics. Her technical expertise, strategic vision, and collaborative approach have been instrumental in driving the company's growth and enabling the advancement of promising drug candidates.
Conclusion
Qianting Zhai is a versatile and visionary biotechnology executive with a proven track record of driving innovation and delivering results. Her deep scientific expertise, coupled with her strong leadership and strategic skills, make her a valuable asset to Abiosciences as it continues to push the boundaries of antibody discovery and development.
